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Summary A diversity of adhesive interactions occur between the cancer cell and host extracellular matrix which potentiate neoplastic
expansion and metastatic dissemination. In miscellaneous malignant diseases, tumour progression has been obse'rved to be associated with
alterations in adhesion molecule expression. Recently, circulating soluble intercellular adhesion molecules have been identified. In this study,
serum levels of soluble intercellular adhesion molecule-1 (sICAM-1) and soluble E-selectin (sE-selectin) were determined in patients with
gastric cancer. The study group consisted of 27 patients with previously untreated gastric adenocarcinoma. Four patients had stage 11, two
patients stage IlIl and 21 patients stage IV disease according to the TNM classification. Nineteen patients had distant metastasis. The sera
obtained from 18 healthy volunteers served as controls. Serum sICAM-1 and sE-selectin concentrations were determined by enzyme-linked
immunosorbent assay (ELISA). In addition, we also studied other tumour-associated antigens, i.e. CEA and CA 19-9. Serum sICAM-1 levels
were significantly increased in patients with gastric cancer (P < 0.0001). However, sE-selectin levels did not differfrom the controls. sICAM-1
concentrations were also significantly higher in patients with distant metastasis and peritoneal spread (P = 0.0045 and P = 0.0157
respectively), whereas sE-Selectin levels were elevated only in patients with peritoneal metastasis (P = 0.033). Serum concentrations of
sICAM-1 and sE-selectin correlated with CEA levels (P = 0.0013 and P = 0.003 respectively). Elevated levels of sE-selectin were associated
with poorer prognosis (P = 0.0099), whereas sICAM-1 had no significant impact on survival. Our results suggest that increased sICAM-1
serum levels may reflect widespread disease and contribute directly to the progression of gastric cancer. Further investigation of the
molecular mechanisms of adhesive tumour-host interactions may lead to a better understanding of the natural history of gastric cancer.
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The outcome of patients with stomach cancer is extremely poor.
Most cases are diagnosed at an advanced stage and the five-year
survival rate is approximately 5-15% (Silverberg et al, 1992). The
major determinant of survival following gastric cancer appears to
be the development of metastases. Identification of biomolecules
involved in the progression and dissemination of gastric cancer
has gained considerable interest in the recent decade. Attachment
factors, proteinases, natural proteinase inhibitors and motility
factors are being investigated in patients with gastric cancer
(Honda et al, 1996; Schwartz, 1996).
Adhesion molecules are distinct membrane surface receptors
that participate in coordinating vital biological events such as
morphogenesis, cell migration and intercellular communication
(Springer, 1990; Carlos and Harlan, 1994; Frenette and Wagner,
1996a,b). There is substantial evidence to suggest that cell-cell
and cell-matrix adhesive interactions play a crucial role in tumori-
genesis, tumour progression and in particular metastasis (Albelda,
1993; Juliano, 1987; Pauli et al, 1990; Tuszynski et al, 1997). The
expression, function and regulation of adhesion molecules are
essential in these complex events and dysfunction or dysregulation
of their equilibrium consequently results in disruption of normal
cellular architecture and differentiation.
Intercellular adhesion molecule-1 (ICAM-1, CD54) is a
member of the immunoglobulin supergene family of adhesion
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proteins which serves as the counter-receptor for a leucocyte inte-
grin adhesion receptor, lymphocyte function-associated antigen-1
(LFA-1) (Marlin and Springer, 1987). The interaction of ICAM-l
and LFA-1 is important in the pathophysiology of the disease,
including tumour progression and metastasis. ICAM-1 has been
shown to be expressed on malignant cells in a number ofhaemato-
logical and non-haematological neoplasms.
Selectins are adhesion molecules that mediate the initial binding
of leucocytes to microvascular endothelium by lectin-type inter-
actions with carbohydrate ligands on corresponding target cells
(Bevilacqua et al, 1991; Bevilacqua and Nelson, 1993). E-selectin
(CD62E) is detected on the surfaces ofendothelial cells upon acti-
vation by cytokines and hence designated by prefix E-, which
stands for endothelium. E-selectin binds to target cell surfaces by
oligosaccharide recognition, specifically to sialyl-Lewis x (sLex).
sLex is not responsible for all E-selectin-mediated adhesion
processes, and the sLea moiety (also known as CA 19-9), which
has been shown to be expressed on adenocarcinomas of gastro-
intestinal tract, is also involved in E-selectin-mediated adhesion
(Majuri et al, 1992).
Adhesion molecules can be detected in soluble forms in the circu-
lation, and raised levels have been reported in several conditions,
including different neoplastic conditions, higher concentrations
being associated with liver metastases in gastrointestinal cancers
(Haming et al, 1991; Tsujisaki et al, 1991; Banks et al, 1993;
Gearing and Newman, 1993; Pui et al, 1993; Christiansen et al,
1996). However, effect on survival was determined only in patients
with malignant melanoma, lymphomas and Hodgkin's disease
(Harning et al, 1991; Pui et al, 1993; Christiansen et al, 1996).
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In this study, we analysed serum levels of sICAM-1 and sE-
selectin in patients with newly diagnosed gastric carcinoma and
determined their relation with metastasis and effect on survival.
PATIENTS AND METHODS
Patients and controls
Serum samples were collected from 27 patients with newly diag-
nosed gastric cancer between June 1995 and February 1996 at the
Department ofMedical Oncology, Hacettepe University Institute of
Oncology, Ankara, Turkey. There were 18 males and nine females
with a median age of60 years (range 33-75). All patients had histo-
logically proven gastric adenocarcinoma. Patient characteristics are
shown in Table 1. Staging was carried out according to the revised
American Joint Committee on Cancer (AJCC) International TNM
system, which is based on post-gastrectomy pathological staging.
Four patients had stage II, two patients stage III and 21 patients
stage IV disease. Nineteen of the stage IV patients had distant
organ-tissue metastases and the remaining two had locally
advanced disease. Eleven patients had peritoneal dissemination,
whereas seven patients could not be evaluated for peritoneal
involvement. Distant organ and lymph node involvement were
documented by chest radiography, abdominal ultrasonography and
computerized tomography. Endoscopic sonography, bone scanning
and bone marrow aspiration and biopsy were performed, ifneeded,
in selected patients. Surviving patients were followed for about one
year with a median of4 months.
The sera obtained from 18 age- and sex-matched healthy
hospital personnel, including 11 men and seven women, served as
controls. Their median age was 51 years (range 24-70 years).
Collection and storage of serum samples
Blood samples were collected following non-traumatic venepunc-
ture before the surgery and/or chemotherapy and allowed to clot at
room temperature for 2 h. The aliquots were separated following
centrifugation for 5 min at 2500 r.p.m. and stored at -30°C until
assayed.
Assay of circulating sICAM-1 and sE-selectin
Serum levels of circulating adhesion molecules sICAM-1 and sE-
selectin were measured with commercial sandwich ELISA assays
(R&D Systems Europe, UK) according to the manufacturer's
instructions. In brief, microtitre plates were coated with a mono-
clonal antibody against one epitope on sICAM-1 and sE-selectin.
Standards and samples were transferred to the coated microtitre
plates and incubated with streptavidin-horseradish peroxidase
conjugate and a biotinylated antibody recognizing a second
epitope on sICAM-1 and sE-selectin. A colour reaction was devel-
oped with tetramethylbenzidine and the absorbance was read at
450 nm with a correction wavelength of620 nm.
Measurement of carcinoembryonic antigen and
carbohydrate antigen 19-9
We also simultaneously measured the levels ofCEA and CA 19-9,
which are established tumour markers for gastric cancer, using
commercially available IMMULITE CEA and CA 19-9 kits
(DPC, CA, USA). CEA is also an adhesion molecule similar in
Table 1 Patient characteristics
Characteristic Number
Patients 27
Male/female 18/9
Median age in years (range) 60 (33-75)
Stage
0
11 4
IlIl (A+B) 2
IV 21
Tumour location
Antrum 13
Corpus 9
Cardia 5
Metastatic disease 19
Peritoneum 11
Liver 11
Bone 4
Bone marrow 2
Lung 2
Performance status (ECOG)
0 4
1 6
2 9
3 3
4 5
structure to the immunoglobulin superfamily. The recommended
cut-off values for CEA and CA 19-9 were 5 ng ml' and 37 U ml
respectively.
Statistical analysis
Data are presented as median and interquartile range [median
(IQR; 75th-25th percentile)]. P-values < 0.05 were assigned to be
significant. Intergroup adhesion molecule concentration compar-
isons were performed by means of the Mann-Whitney U-test. For
correlations between sICAM-1 and sE-selectin and other tumour-
associated antigens, the Spearman's rank correlation test was
utilized. Cut-off levels of sICAM-1 and sE-selectin values were
determined using 'receiver operator characteristics' (ROC)
analysis. Sensitivity, specificity and positive and negative predic-
tive values for metastasis were calculated. Survival analysis was
estimated by the Kaplan-Meier method and examined by the log-
rank test. Data were analysed using 'Statistical Package for Social
Sciences (SPSS) v 5.01 for Windows' computer program.
RESULTS
Concentrations of circulating sICAM-1 and sE-selectin
in gastric cancer
Serum concentrations of sICAM-1 in gastric cancer patients were
significantly elevated, whereas sE-selectin levels did not differ
from those in normal controls. sICAM-I and sE-selectin levels
were 408.4 (202.2) ng ml-'vs 279.85 (95.80) (P < 0.0001) and 66.0
(46.0) ng ml-' vs 59.95 (32.40) ng ml-' (P = 0.4584) respectively
(Figure 1).
As shown in Table 2, serum levels of sICAM-1 were signifi-
cantly increased in gastric cancer patients with distant organ
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Figure 1 Serum levels of sICAM-1 and sE-selectin in gastric cancer patients and controls
and/or tissue metastases [441.60 (374.4) ng ml-'] compared with
patients without metastases [304.4 (88.3) ng ml-'] (P = 0.0045).
sE-selectin levels appeared to be elevated in metastatic gastric
cancer patients [70.0 (38.0) ng ml-'] compared with patients
without distant metastases [55.0 (38.0) ng ml-']; however, the
differences did not reach statistical significance (P = 0.144)
(Figure 2).
Adhesion molecule levels were also evaluated according to peri-
toneal involvement (Table 2). Higher levels of sICAM- were
noted in patients with peritoneal spread [441.60 (174.6) ng ml-']
than in patients without peritoneal implants [296.0 (108.8) ng ml-']
(P = 0.0157). In patients with peritoneal involvement, sE-selectin
concentrations were also significantly raised compared with
patients without peritoneal metastases [84.0 (34.0) ng ml-' vs 51.0
(34.0) ng ml-'; P = 0.033] (Figure 3).
Correlation of sICAM-1 and sE-selectin with
tumour-associated antigens
Serum levels of sICAM-1 and sE-selectin did not correlate with
each other, nor with serum CA 19-9 levels (data not shown). A
significant correlation was, however, found between CEA serum
levels and the levels ofboth adhesion molecules sICAM- 1 and sE-
selectin (moderate positive correlation, r = 0.50 and P = 0.0013 vs
r = 0.57 and P = 0.003 respectively).
Prognosis and the serum adhesion molecule levels
ROC curve analysis revealed the presence of significant cut-off
values for sICAM- 1 (z = 4.42, one-tailed P < 0.001) and sE-
selectin (z = 1.88, one-tailed P = 0.031) with reasonable predictive
values for metastasis. Cut-off levels for sICAM- and sE-selectin
Table 2 Serum concentrations (ng ml-') of sICAM-1 and sE-selectin in
patients with gastric cancer
sICAM-1 P sE-selectin P
Median (IOR) Median (IQR)
Gastric cancer (n = 27) 408.4 (202.2) 0.0001 66.0 (46.0) 0.4584
Controls (n = 18) 279.85 (95.80) 59.95 (32.40)
Distant metastasis
Present (n = 19) 441.60 (374.4) 0.0045 70.0 (38.0) 0.144
Absent (n = 8) 304.4 (88.3) 55.0 (38.0)
Peritoneal metastasis
Present (n = 11) 441.60 (174.6) 0.0157 84.0 (34.0) 0.033
Absent (n = 9) 296.0 (108.8) 51.0 (34.0)
were determined as 380 ng ml-l and 70 ng ml respectively.
Sensitivity, specificity and positive and negative predictive values
were calculated according to the cut-off values (Table 3). Gastric
cancer patients with serum sE-selectin levels over 70 ng ml'
proved to have a significantly shorter overall survival than those
with lower serum concentrations (P = 0.0099) (Figure 4). Serum
sICAM-1 levels did not significantly affect survival (P = 0.1390).
Early death of the majority of the patients during follow-up
might be responsible for this unexpected result. Finally, higher
CEA levels, but not CA 19-9 levels, indicated worse prognosis
(P = 0.0408 vs P = 0.2080).
DISCUSSION
Neoplastic transformation and the evolution to metastatic disease
are characterized by a dramatic aberration in cellular cohesive
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Figure 2 Serum sICAM-1 and sE-selectin levels in metastatic and non-
metastatic gastric cancer patients. Error bars represent the dispersion of
sICAM-1 and sE-selectin values. Edges of each box correspond to 25th and
75th percentiles and the thicker middle bars indicate the medians
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Figure 4 Patient survival according to sICAM-1 (A) and sE-selectin (B)
levels
e{Ijh and, therefore, enhance the invasion oftumour cells into the tissue
01l parenchym a at the m etastatic site.
0 200 400 600 800 1000 Malignant cells possess many membrane surface antigens that
sICAM-1(ng ml-') regulate fundamental cellular functions, including the MHC
antigens, differentiation antigens, tumour-specific receptors and
:erum sICAM-1 and sE-selectin levels in gastric cancer patients tumour-associated antigens (Black, 1980). These antigens are shed
Dut peritoneal metastasis. Error bars represent the dispersion of
Id sE-selectin values. Edges of each box correspond to 25th and into the circulation and usually reflect the extent of the disease.
tiles and the thicker middle bars indicate the medians Molecules mediating leucocyte-endothelium adhesion may serve
as tumour-associated antigens in a variety ofsolid tumours (Black,
1980). ICAM-1, together with MHC antigens, plays an important
ns (Albelda, 1993; Juliano, 1987; Pauli et al, 1990; role in the human immune response, involving T-cell activation
et al, 1997). Adhesion proteins are involved in many of and other lymphocyte effector functions. ICAM-1 and MHC anti-
tediate steps ofmetastatic cascade and are likely to show gens are frequently coexpressed on the gastric carcinoma cells
-d changes in expression during malignant progression. which may suggest a possible contribution of the immune system
ells invade the surrounding connective tissue and are to the dissemination ofthe tumour (Koyama et al, 1992; Ishii et al,
away from their primary localization after the disruption 1994). Moreover, adhesion molecule shedding from the surface of
,tions between neighbouring cells. Circulating tumour the cancer cell may represent an important mechanism for tumour
Ihere selectively to the microvascular endothelium ofthe cells to escape immunosurveillance.
econdary target organ site. This process is suggested to In this report, we have demonstrated that concentrations of
ted by organ-specific adhesion molecules, which are sICAM-1 are increased in gastric cancer, especially in patients
on the endothelial cells of the preferred site and which with distant organ and peritoneal metastases. sE-selectin levels did
'homing receptors' (Pauli et al, 1990). These adhesion not differ from the controls in patients with gastric cancer and in
have also been shown to facilitate tumour cell motility metastatic patients, but were elevated significantly in patients with
Table 3 sICAM-1, sE-selectin, CEA and CA 19-9 sensitivity, specificity, positive and negative predictive values
Cut-off (ng ml-') Sensitivity (%) Specificity (%) PPV (%) NPV (%)
sICAM-1 380 73.7 87.5 93.3 53.8
sE-selectin 70 47.4 87.5 90.0 41.2
CEA 5.5 51.7 94.4 93.3 56.6
CA 19-9 (U ml-') 33 55.5 88.9 88.2 57.1
PPV, positive predictive value; NPV, negative predictive value.
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peritoneal metastases. For sICAM-1, these findings confirm data
published previously in the literature. However, in contrast, only
higher (> 70 ng ml-') sE-selectin levels indicated worse prognosis
in survival analysis, although sICAM-1 levels had no significant
impact on survival. Serum levels ofsICAM-1 and sE-selectin were
correlated with serum CEA levels, but not with CA 19-9 levels.
The significant correlations found between sICAM-1 or sE-
selectin and CEA probably reflect the similar nature ofthese mole-
cules, which function as adhesion molecules.
Little is known about the expression and functions of adhesion
molecules in gastric cancer. ICAM-1 was shown to be expressed on
the surface of primary and metastatic gastric carcinoma cells
(Koyama et al, 1992;Ishii et al, 1994; Mayer et al, 1995; Nasu et al,
1997), but no correlation with survival was found (Mayer et al,
1995). Mizoi et al (1995) described positive staining of stromal
macrophages with ICAM-I and of lymphocytes with LFA-1 along
the invasive margin ofgastric cancer, and suggested a possible role of
ICAM-l/LFA-I interaction in host immune/inflammatory reaction.
Contradictory results have also been reported in the literature. Ura
et al (1996), in contrast to our study, demonstrated that the expression
ofICAM-1 was inversely correlated with liver metastasis. Yasoshima
et al (1996) also showed a reduced expression of ICAM-I and of
LFA-1 and increased surface expression ofP1 integrins in an experi-
mental animal model ofhigh-metastatic gastric cancer cell line.
Data on circulating adhesion molecules in gastric cancer are
insufficient. Our results confirm and augment data reported by
Tsujisaki et al (1991), who detected increased levels of sICAM-1 in
the sera of gastric cancer patients, with particularly higher levels in
patients with liver metastases. They also demonstrated that both
expression and shedding of ICAM-I antigen increased when
cultured gastric carcinoma cells were treated with interferon-y.
Banks et al (1993) examined the serum concentrations of adhesion
molecules sE-selectin, sICAM-1 and cVCAM-1 in randomly
selected cancer patients. The levels of all three adhesion receptors
were found to be elevated in patients with gastrointestinal cancer,
but the exact localization of the tumours were not specified.
Moreover, the significance ofadhesion molecule levels in metastatic
disease was not determined, but it was stated that 85% of all cases
with epithelial tumours were metastatic. The prognostic significance
ofadhesion molecules were not determined in either study.
In conclusion, the results of this study provide strong circum-
stantial evidence that alterations in the expression and function of
adhesion molecules may play a critical role in the aggressive
behaviour of gastric cancer. We have shown that the serum concen-
trations of sICAM-I are significantly elevated in gastric cancer.
The level ofsICAM-1 reflected metastatic dissemination and corre-
lated with a well-known tumour-associated antigen, CEA. The
functional role and pathophysiological consequences of elevated
levels of sICAM- 1 need to be further investigated. The identifica-
tion of the peculiar mechanisms of the adhesion molecule aberra-
tions may lead to a better understanding of the natural history of
gastric cancer and also ofother solid epithelial malignancies.
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